stress is also involved in the pathogenesis of AV calcification remains unknown.
Histological data demonstrate the presence of oxidized low-density lipoprotein (oxLDL) in calcified AV, indicating its pathophysiological role in the development of AV calcification. 11 Furthermore, several groups have recently demonstrated that oxLDL could trigger ER stress in endothelial cells, thus playing an important role in the development of atherosclerosis. 12, 13 These studies suggest that ER stress may be induced during AV calcification.
Recent studies reported that ER stress-mediated activation of activating transcription factor 4 (ATF4) and spliced X-boxbinding protein 1 (XBP1s) are transcriptional activators that control the important osteoblastic differentiation factors osteocalcin and Runx2. [14] [15] [16] Moreover, an emerging function of ER is to regulate inflammation because studies have indicated that unfolded protein response causes activation of c-Jun N-terminal kinase (JNK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathways. 17, 18 Notably, activation of the inflammatory response is also a key contributor to AV calcification development. 5, 19, 20 We therefore hypothesized that ER stress may contribute to osteoblastic differentiation and inflammation in VICs to promote AV calcification.
To test this hypothesis, we investigated the presence of ER stress in calcified AV from patients with CAVS and experimental AV calcification in animal models. Because oxLDL plays an important role in AV calcification development and may potentially cause ER stress, we examined the association between oxLDL and ER stress-mediated inflammation and osteoblastic differentiation in cultured VICs. Furthermore, we determined whether a classical ER stress inhibitor, tauroursodeoxycholic acid (TUDCA), could attenuate diet-induced AV calcification via alleviation of ER stress in AV calcification animal models.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

ER Stress Is Activated in AV Leaflets of Patients With CAVS
To determine whether ER stress is induced in patients with AV calcification, we used AV tissues from 10 patients with CAVS, as well as 4 traffic accident victims. In parallel with the increased expression of Runx2 and osteocalcin, we found marked activation of ER stress in calcified AV compared with the control subjects as assessed by PERK and IRE1α phosphorylation, and C/EBP homologous protein (CHOP) expression (Figure 1 ).
High-Cholesterol Diet Induced Significant AV Calcification in Animals
We used 2 different classical animal models of AV calcification, rabbits and mice, which are similar to human clinical condition. 19, [21] [22] [23] [24] After 12 weeks of high-cholesterol (HC)+vitamin D 2 (vitD 2 ) diet, increased echogenicity occurred in AV of HC+vitD 2 -treated rabbits ( Figure II in the online-only Data Supplement). AV area (AVA) and AVA indexed by body surface area in HC+vitD 2 -treated rabbits decreased markedly compared with the normal controls ( Table 1) . We also observed a significant increase in transvalvular peak jet velocity and a marked decrease in AVA and AVA index after 24 weeks of HC diet treatment in ApoE −/− mice (Table 1) . We next assessed the degree of calcification. Alizarin red staining revealed increased calcium deposit in HC+vitD 2 rabbits compared with normal controls (Figure 2A and 2B). The transition from VICs to myofibroblasts is also a critical change in valvular pathology. 4 We examined myofibroblasts in AV by immunohistochemical staining using α-smooth muscle actin (α-SMA) antibody. AV in control animals exhibited sparse α-SMA positive myofibroblasts, whereas HC+vitD 2 treatment markedly increased the α-SMA positive staining area ( Figure  III in the online-only Data Supplement).Similarly, we also observed significant calcium deposits in AV of HC diet-treated ApoE −/− mice by alizarin red staining (Figure 2A and 2C ). The expression of α-SMA was markedly increased in HC-treated ApoE −/− mice ( Figure IV in the online-only Data Supplement).
Activation of ER Stress in Calcified AV of Hypercholesterolemic Animals
We examined whether ER stress was induced in AV leaflets of AV calcification animals. Results showed that both HC+vitD 2 treatment in rabbits and HC treatment in ApoE −/− mice markedly increased the AV ER stress response compared with normal controls, as evaluated by staining of ER stress markers Immunoblotting for osteoblast differentiation markers Runx2 and osteocalcin, and ER stress markers in AV leaflet samples from patients with CAVS as well as normal leaflets. Runx2 and osteocalcin expressions were strongly induced, and the expressions of phosphorylated-protein kinase-like ER kinase (p-PERK), phosphorylated-inositol-requiring transmembrane kinase and endonuclease-1α (p-IRE1α), and C/EBP homologous protein (CHOP) were markedly increased in calcified AV compared with normal AV (**P<0.01 vs normal). Figure 3A) . Moreover, immunoblotting showed that important ER stress markers, such as p-PERK and p-IRE1α, and CHOP expression were significantly induced in AV of HC+vitD 2 -treated rabbits compared with controls ( Figure VA and VB in the online-only Data Supplement).
KDEL and CHOP (
Prevention of ER Stress by TUDCA Attenuated Diet-Induced AV Calcification in Animals
TUDCA is a chemical chaperone that has been well demonstrated to be a classical inhibitor against ER stress by improving ER folding capacity both in vitro and in vivo. [25] [26] [27] We examined whether relieving ER stress by TUDCA could rescue AV calcification. We treated HC+vitD 2 -fed rabbits with TUDCA (50 mg/kg per day) by oral gavage. In parallel with the attenuated ER stress in HC+vitD 2 +TUDCA group ( Figure 3A) , we found TUDCA supplementation also reduced AV echogenicity ( Figure II in the online-only Data Supplement) and restored AVA index compared with HC+vitD 2 group (Table 1) . Furthermore, TUDCA significantly suppressed calcium deposit ( We also evaluated whether TUDCA administration could prevent HC diet-induced AV calcification in ApoE −/− mice. Twenty-four consecutive weeks of TUDCA (0.5 g/kg per day) oral gavage significantly reduced levels of AV ER stress markers KDEL and CHOP staining ( Figure 3B ), prevented transvalvular peak jet velocity increases, restored AVA index (Table 1) , and reduced calcium deposits ( 
TUDCA Administration Prevented HC TreatmentInduced Osteoblastic Differentiation in AV Leaflets
We determined whether ER stress links AV osteoblastic differentiation in AV calcification animals. As shown in Figures IV and V in the online-only Data Supplement, HC+vitD 2 diet markedly increased Runx2 staining as well as protein and mRNA expression of important osteoblastic differentiation markers, osterix, Runx2, and osteocalcin, in AV leaflets in rabbits. Consistent with the results in AV calcification rabbits, AV staining of osterix, Runx2, and osteocalcin were all markedly increased after 24 weeks of HC diet treatment in ApoE −/− mice ( Figure 4A-4D ). As expected, ER stress inhibitor TUDCA administration significantly inhibited these effects in both rabbit and mouse models of AV calcification ( 
TUDCA Protected Against Leaflet Inflammation in Diet-Induced AV Calcification Animals
Direct involvement of the ER stress-mediated pathway in the inflammatory response has been described in some reports, 28 but not in a model of AV calcification. We evaluated the effect of in vivo TUDCA administration on the level of inflammation in AV leaflets. Results showed that hypercholesterolemic animal models of AV calcification markedly increased macrophage infiltration in AV leaflets as indicated by macrophage markers RAM11 and F4/80, respectively ( 
Effects of TUDCA Are Independent of Serum Lipid or Blood Glucose Levels
We compared the metabolic parameters among groups and found that there were no differences observed in levels of plasma glucose, total cholesterol, LDL, and triglycerides among groups at baseline (Table II in the online-only Data Supplement). Significant increases in serum cholesterol and LDL levels were observed in both animal models of AV calcification after the indicated diet treatments, whereas TUDCA treatment did not alter either the lipid profiles or glucose levels compared with the HC+vitD 2 or HC diet-fed animals ( Table 2) .
OxLDL Induced ER Stress in VICs in a Cytosolic [Ca] 2+ i -Dependent Manner
OxLDL presents in calcified AV, 11 and therefore we investigated whether oxLDL could trigger ER stress in cultured VICs. Results showed that oxLDL induced marked ER stress in VICs in a dose-dependent manner as evaluated by expression of ER stress markers ( Figure VIIIA and VIIIB in the online-only Data Supplement).
It has been reported that oxLDL could increase cytosolic [Ca] 2+ i in various cell types. 29, 30 We found incubation of oxLDL led to a significant increase in cytosolic [Ca] 2+ i
( Figure VIIIC in the online-only Data Supplement). Moreover, as with oxLDL, incubation of VICs with a calcium ionophore A23187 markedly enhanced ER stress, and, by contrast, pretreatment with calcium chelator BAPTA-AM effectively protected VICs from ER stress induced by both oxLDL and A23187 ( Figure VIIID and VIIIE in the onlineonly Data Supplement).
ER Stress Promoted OxLDL-Induced Osteoblastic Differentiation Via PERK/ATF4/Osteocalcin and IRE1α/XBP1s/Runx2 Signaling in VICs
It has been reported that the important osteoblastic factors osteocalcin and Runx2 are the downstream targets of ATF4 and XBP1s, respectively, which are activated during ER stress. [14] [15] [16] We therefore examined whether oxLDLs trigger osteoblastic differentiation in VICs via ER stress activation. As Figure 5A and 5B depicted, small interfering RNA silencing of PERK ( Figure 
ER Stress Is Involved in OxLDL-Activated Inflammation Through IRE1α-Mediated JNK and NF-κB Signaling in VICs
We further explored whether oxLDL could lead to inflammation via the ER stress-mediated IRE1α pathway. 31 Results showed that small interfering RNA silencing of IRE1α markedly reduced JNK phosphorylation triggered by oxLDL ( Figure 5E ). Meanwhile, as expected, IRE1α silencing also reduced oxLDL-induced nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) degradation and NF-κB p65 nuclear translocation ( Figure  5F and 5G) . 
Inhibition of ER Stress Reduced OxLDLInduced Osteoblastic Differentiation and Inflammation in VICs
We further investigated whether inhibition of ER stress would protect VICs from oxLDL-induced osteoblastic differentiation and inflammation. We found that TUDCA and 4-phenyl butyric acid (4-PBA), 2 classical ER stress inhibitors with distinct chemical structures, markedly attenuated ER stress triggered by oxLDL in VICs (Figure 6A and 6B; Figure XII in the online-only Data Supplement). We assayed the effects of TUDCA and 4-PBA, and found that they both markedly reduced Runx2 and osteocalcin expression induced by oxLDL incubation in VICs ( Figure 6C ; Figure XIII in the online-only Data Supplement). We next explored the effects of TUDCA and 4-PBA on JNK and NF-κB signaling. Results showed that TUDCA and 4-PBA pretreatments both effectively inhibited the activation of JNK caused by 
Discussion
Despite the clinical importance of heart disease and intense study in this field, the mechanisms underlying the development of AV calcification remain unclear. The present study suggests the important role of ER stress in the pathogenesis of AV calcification. We identified significant ER stress induction in calcified AV of patients with CAVS. In our hypercholesterolemia-induced AV calcification animal models, we also found ER stress activation in AV leaflets. Inhibition of ER stress by TUDCA administration was associated with significant benefits on AV calcification and could markedly attenuate AV osteoblastic differentiation and inflammation. Our in vitro experiments subsequently indicate that oxLDL causes ER stress in VICs by increasing cytosolic [Ca] 2+ i
. Furthermore, we provide evidence that oxLDL induces osteoblastic differentiation via ER stress-mediated PERK/ATF4/osteocalcin and IRE1α/XBP1s/Runx2 pathways, and oxLDL promotes inflammatory responses via ER stress-mediated IRE1α/JNK and NF-κB signaling. Inhibition of ER stress by either TUDCA or 4-PBA could suppress osteoblastic differentiation, inflammatory response, and mineralization induced by oxLDL in VICs.
AV Calcification and ER Stress Activation
AV calcification development shares some similarities with atherosclerosis and arterial calcification. 32 It has been widely accepted that ER stress plays an important role in atherosclerotic plaque progression, 33, 34 and in vitro data indicate the potential role of ER stress in arterial calcification development.
14 However, whether there is a link between ER stress and AV calcification has not been reported to date. In this present work, we used calcified AV tissue samples from patients with CAVS, as well as 2 classical hypercholesterolemic AV calcification animal models to explore their links.
Lipoprotein deposition, osteoblastic differentiation, and inflammation all markedly contribute to AV calcification and its subsequent CAVS in humans. 4 In this study, we identified upregulation of ER stress markers in patients with significant CAVS. Moreover, we observed that ER stress was markedly induced in AV leaflets in 2 distinct AV calcification models of 2 species, further suggesting that ER stress activation in AV leaflets potentially correlates with AV calcification development.
Although the above data implicate ER stress in induction of calcified AV, how ER stress is initiated is still unknown. To date, oxLDL is associated with proinflammatory and mineralization promoting properties 35, 36 to induce AV calcification. 11 Our current results add another dimension to oxLDL and provide evidence that oxLDL contributes to ER stress in AV calcification. Here, we showed that oxLDL stimulation causes strong ER stress in VICs. As previously documented, increased cytosolic [Ca] 2+ i hampers ER abilities of protein folding, causes unfolded or misfolded protein accumulation, and could finally lead to ER stress. in smooth muscle cells and endothelium cells. 13, 29 Providing additional support to this hypothesis, we demonstrated that administration of A23187, a calcium ionophore, could also strongly induce ER stress in VICs. Moreover, we found that oxLDL or A23187-induced ER stress could be attenuated by reducing cytosolic [Ca] 2+ i
. These findings suggest that oxLDL-induced ER stress in VICs is mediated in a cytosolic [Ca] 2+ i -dependent manner.
ER Stress Links Osteoblastic Differentiation and Inflammation
Activation of osteoblastic differentiation in VICs has been proven to play a central role during AV calcification development. 4 ATF4 and XBP1s are critical transcription factors downstream of PERK and IRE1α signaling branches of ER stress, and they play important roles in the recovery of damaged cells exposed to ER stress. 6 Recent studies indicate that ATF4 and XBP1s mediate not only ER stress responses but also osteoblastic differentiation because they are transcriptional activators of osteocalcin and Runx2, the central regulators of osteoblastic differentiation. 15, 16 Using small interfering RNA silencing strategy, we provided evidence that ER stress-mediated PERK/ATF4 and IRE1α/XBP1s signaling is responsible for osteocalcin and Runx2 expression, and thus directly contributes to oxLDL-induced osteoblastic differentiation in VICs.
Recent studies revealed that chronic inflammation contributes to the development of AV calcification. Accumulating infiltrated inflammatory cells are major sources of matrix metalloproteinases and cysteine endoproteases, which degrade collagen and elastin in the valvular extracellular matrix, thereby resulting in valvular dysfunction and further activation of osteoblastic differentiation. 38 As a growing body of evidence suggests that ER stress can lead to inflammation, 28, 31, 39 ER stress may also contribute to AV calcification via promotion of inflammatory responses. We explored the role of the IRE1α pathway, shown to be linked with JNK and NF-κB signaling. 17, 18 We found that JNK was activated by oxLDL, in agreement with previous reports, 40 and that silencing IRE1α blocked the phosphorylation of JNK. Furthermore, NF-κB nuclear translocation induced by oxLDL could also be prevented by IRE1α silencing. Both NF-κB and JNK activation induced the expression of the inflammatory genes. 28 Our data further suggest that IRE1α silencing could, in part, inhibit the oxLDLinduced inflammatory genes expression, in agreement with the role of IRE1α/JNK and IRE1α/NF-κB, in inflammation. 31 The NF-κB pathway regulates expression of a wide variety of genes that are involved in inflammatory responses. 41 Moreover, it has been reported that NF-κB signaling mediates Runx2 and osteocalcin expression, and promotes osteoblastic differentiation. 20, 42, 43 In our experiment, we showed that NF-κB inhibition significantly suppressed oxLDL-stimulated inflammatory responses, and the expression of Runx2 and osteocalcin as well. These results indicate that NF-κB activation mediates oxLDL-induced proinflammatory effects and osteoblastic differentiation in VICs.
Inhibition of ER Stress as a Therapeutic Approach to AV Calcification
Chemical chaperones, such as TUDCA and 4-PBA, enhance the ER folding ability to prevent protein aggregation, and thus have the ability to alleviate ER stress. 27 In this study, we found TUDCA and 4-PBA protected against oxLDLinduced ER stress in VICs. Concomitant with reduced ER stress, these 2 structurally distinct ER stress inhibitors significantly suppressed osteoblastic differentiation and inflammatory responses induced by oxLDL in VICs, and therefore add strength to the proposal that the oxLDL-triggered osteoblastic differentiation and inflammation in VICs is, at least in part, induced via ER stress.
Altogether, the results provide support to the hypothesis that ER stress in AV leaflets is associated with AV calcification development. Furthermore, these implications raise a crucial question: whether reducing AV ER stress could be used as a strategy to alter the progression of AV calcification. The chemical chaperone TUDCA has been proven to be protective in various diseases, such as diabetes mellitus, obesity, and atherosclerosis, via prevention of ER stress. [25] [26] [27] We also found that TUDCA protected against hypercholesterolemia-induced AV calcification in animal models. TUDCA administration significantly reduced leaflet ER stress activation, prevented osteoblastic differentiation and inflammation, and attenuated AV calcification development. These protective effects were independent of serum lipid or glucose metabolism and were demonstrated to act via inhibition of AV ER stress, further implicating the involvement of ER stress in AV calcification development.
The most striking result in the present study was that TUDCA administration could significantly reduce the development of AV stenosis, which might lead to a novel therapeutic approach. Several clinical trials indicate that ER stress-inhibitor chemical chaperones could improve liver and muscle insulin sensitivity in obese subjects, while ER stress plays an essential role in insulin resistance and diabetes mellitus development. 44 Our study provides evidence that ER stress inhibitors might be protective against AV calcification in humans.
Many other clinical conditions other than hypercholesterolemia may contribute to the development of AV calcification. Studies indicate that chronic kidney disease is closely associated with AV calcification; increased parathyroid hormone and inflammation might contribute to this. 45 Recently, Zhou et al 46 reported that chronic kidney disease could lead to vascular ER stress activation and cause insulin resistance. Although further studies are required, this may provide additional evidence supporting our findings and suggests that ER stress may also play an important role during chronic kidney disease-induced AV calcification. Patients with bicuspid AV malformation develop AV calcification and stenosis spontaneously at an early age. 47 Local blood turbulence and inflammation may be the major contributor to the development of AV calcification in bicuspid AV malformation, 48 and the role of ER stress in such a condition needs further investigation.
Evidence suggests that AV calcification possesses characteristics of arterial calcification, and both share similar epidemiological risk factors. 49 Inflammation and osteoblastic differentiation play a key role in the development of both these conditions. 50, 51 In the absence of in vivo data, Masuda et al 14 and Saito et al 16 reported that stearate and bone morphogenetic protein 2 stimulated osteoblastic differentiation in vascular smooth muscle cells via activating ER stress. This is similar to our study that shows that oxLDL triggers osteoblastic differentiation via ER stress-mediated PERK/ATF4/osteocalcin and IRE1α/XBP1s/Runx2 signaling in VICs. However, arterial calcification and AV calcification development are mediated through differential processes. In AV calcification, VICs should first be activated by various stimuli to become α-SMA-containing activated VICs, which are then further differentiated into osteoblast-like VICs, 4 whereas vascular smooth muscle cells are already α-SMA positive and can be directly stimulated into osteoblast-like cells. 52 With respect to these important differences between arterial calcification and AV calcification, future studies are required to verify the links between ER stress and arterial calcification in vivo.
Although LDL and oxLDL are closely associated with AV calcification and CAVS development, recent randomized clinical trials of statins on CAVS led to conflicting results, which did not show protective effects on CAVS development. [53] [54] [55] In addition, recent studies indicate statin therapy for vascular calcification seemed to paradoxically accelerate vascular calcification. 56, 57 In addition to the well-established lipid lowering and anti-inflammatory effects of statins, several reports suggested that statins could also trigger ER stress. [58] [59] [60] This implies that induction of ER stress by statins may be one of the mechanisms limiting their therapeutic efficacy in CAVS. Moreover, our study showed that inhibition of ER stress did not alter lipid profiles, suggesting this as a potential approach to managing osteogenic differentiation, independent of classical risk factors.
Limitations
One limitation in our study is the limited number of human normal AV samples available. Our previous report demonstrated that valve tissues of patients with cardiomyopathy receiving heart transplantation strongly exhibit ER stress activation because of severe heart failure, 9 and therefore these samples are unfortunately not suitable to serve as a negative control in our study. Furthermore, we only used small interfering RNAs against ER stress signaling to support the potential roles of ER stress-mediated osteoblastic differentiation and inflammation in AV calcification in vitro. Because IRE1α or XBP1 deficiency both cause embryonic lethality in mice, and PERK or ATF4 deficiency in mice spontaneously develop diabetes mellitus or skeletal dysplasia, respectively, 17 these potential targets are thus unavailable or not suitable for in vivo study.
In summary, we demonstrate that ER stress is involved in the pathogenesis of AV calcification. Specifically, oxLDL promotes osteoblastic differentiation and inflammation, at least in part via activating ER stress, and ultimately promotes AV calcification. Inhibition of ER stress markedly relieved ER stress, inhibited osteoblastic differentiation and inflammation in VICs, and attenuated AV calcification development in hypercholesterolemia animals. The proposed mechanism is outlined in Figure XVIII in the online-only Data Supplement.
These results collectively indicate that ER stress may be a novel target against AV calcification.
